J&J cuts 2 deals for diabetes treatment (Associated Press, 23 June 2010)
23 Jun 2010
Johnson & Johnson will soon add to its portfolio of diabetes therapy by partnering up with two companies, one Swedish one Californian, in two separate deals to develop new medicines for type-1 and type-2 diabetes.
